Newsletter

Menu

Celgene plunges to new 52-week low despite beating Q3 estimates

By Staff Correspondent |

Celgene Corp. (CELG) reported better-than-expected profit and revenue numbers for the third quarter of 2018 on strong product sales. Revenue climbed 18% to $3.89 billion and EPS jumped 20% to $2.29,  while analysts predictions for revenue and EPS stood at $3.83 billion and $2.23, respectively.

The pharma company’s stock rose about 3% before the bell. However, the stock failed on to hold its early gains and was trading in the negative territory when the market opened and plunged to its yearly low within few minutes during Thursday’s morning session.

Celgene third quarter 2018 Earnings Infographic

The Summit, NJ-based company lifted its revenue outlook to around $15.2 billion versus the previous guidance of around $15 billion. While the company increased its adjusted EPS outlook to $8.75-8.80 from the prior estimate of $8.70-8.75, it cut down its GAAP EPS outlook to $5.25-5.75 from the earlier target of $5.95-6.25.

The company also reaffirmed its revenue outlook of $19-20 billion and adjusted EPS target of achieving greater than $12.50 for 2020.

“Excellent top- and bottom-line momentum in the third quarter supports raising our 2018 financial guidance,” said CEO Mark Alles. He added, “We are focused on shaping Celgene’s future by rapidly advancing our late-stage pipeline, accelerating promising early research programs, and strengthening the organization.”

Celgene stock rises on upbeat Q2 results, lifts outlook

Product sales swelled 18% year-over-year to $3.89 billion, which comprises sales growth of Revlimid (+18%), Pomalyst/Imnovid (+23%), Otezla (+40%) and Abraxane (+15%). Celgene expects to launch five new late-stage products through 2020.

Today, Celegene’s peers Merck (MRK) and Bristol-Myers Squibb (BMY) reported mixed results for their recently ended quarter. Both the companies surpassed the consensus’ earnings estimates, but fell short of revenue predictions and were trading in the negative zone when the market opened.

Shares of Celgene have slipped 28% for the year-to-date period and 38% for the 52-week period, respectively. The stock hit its yearly high ($121.60) exactly on the same day last year.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Advertisement

More on this Company

Thermo-Fisher Q4 2025 Earnings

Thermo Fisher Q4 revenue, earnings beat estimates; stock drops on weak guidance

January 29, 2026
ipo news

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

September 27, 2022
Biogen Q3 2021 earnings

Biogen posts Q3 earnings well above estimates

October 20, 2021

44 responses to “Celgene plunges to new 52-week low despite beating Q3 estimates”

  1. Bulk URL Shortener

    […]we like to honor several other online internet sites around the internet, even though they aren’t linked to us, by linking to them. Under are some webpages really worth checking out[…]

  6. undetected battlefield v cheats

    […]Wonderful story, reckoned we could combine several unrelated information, nevertheless seriously really worth taking a search, whoa did one particular find out about Mid East has got additional problerms at the same time […]

  8. black frenchies

    […]although internet sites we backlink to beneath are considerably not associated to ours, we feel they are basically really worth a go through, so possess a look[…]

  9. alexa collins

    […]just beneath, are quite a few completely not related web sites to ours, nevertheless, they may be surely worth going over[…]

  11. 늑대닷컴

    […]we like to honor lots of other world-wide-web websites on the internet, even though they aren’t linked to us, by linking to them. Below are some webpages worth checking out[…]

  15. we buy dogs

    […]Every after in a though we decide on blogs that we study. Listed below are the latest web pages that we opt for […]

  19. surrogacy mexico

    […]that may be the end of this post. Here you’ll come across some web pages that we think you will enjoy, just click the hyperlinks over[…]

  21. nepo hat

    […]we like to honor numerous other online web-sites on the internet, even if they aren’t linked to us, by linking to them. Beneath are some webpages worth checking out[…]

  22. sui

    […]very few web-sites that transpire to be detailed beneath, from our point of view are undoubtedly very well worth checking out[…]

  29. frenchie bully mix

    […]Wonderful story, reckoned we could combine a handful of unrelated information, nonetheless seriously worth taking a appear, whoa did one particular understand about Mid East has got a lot more problerms too […]

  30. french bulldog chihuahua mix

    […]we like to honor lots of other online web sites on the web, even when they aren’t linked to us, by linking to them. Underneath are some webpages really worth checking out[…]

  32. Dog Papers

    […]we like to honor many other internet web sites around the net, even when they aren’t linked to us, by linking to them. Under are some webpages worth checking out[…]

  35. Dog Registry

    […]very couple of web sites that come about to be in depth below, from our point of view are undoubtedly properly worth checking out[…]

  37. rent a yacht in cancun

    […]although sites we backlink to below are considerably not associated to ours, we feel they’re really worth a go through, so possess a look[…]

  40. playnet casino

    […]Every after in a even though we select blogs that we study. Listed beneath would be the most up-to-date websites that we opt for […]

  42. clima en atizapán de zaragoza

    […]Wonderful story, reckoned we could combine a few unrelated information, nonetheless really really worth taking a appear, whoa did a single learn about Mid East has got much more problerms at the same time […]

  44. vacation rentals isla mujeres

    […]we like to honor lots of other world wide web sites around the web, even if they aren’t linked to us, by linking to them. Beneath are some webpages really worth checking out[…]

Top